Immune checkpoint inhibitors and chemotherapy versus chemotherapy for early triple-negative breast cancer (protocol)

Ya Gao, M Liu, L Liu, J Zhang, F Song, J Tian

Research output: Contribution to journalArticlepeer-review

2 Downloads (Pure)

Abstract

Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To assess the efficacy and safety of PD-1 inhibitors or PD-L1 inhibitors plus chemotherapy compared with chemotherapy for people with early triple-negative breast cancer.

Original languageEnglish
Article numberCD015072
JournalCochrane Database of Systematic Reviews
Volume2022
Issue number9
DOIs
Publication statusPublished - 26 Sep 2022

Cite this